Demographic, Premorbid, and Clinical Characteristics of Schizophrenia Spectrum Patients with High and Low Polygenic Liability to the Disorder.

Margarita Alfimova, Marina Gabaeva, Tatyana Lezheiko, Victoria Plakunova, Yulia Chaika, Vera Golimbet
Author Information
  1. Margarita Alfimova: Mental Health Research Center, 115522 Moscow, Russia. ORCID
  2. Marina Gabaeva: Mental Health Research Center, 115522 Moscow, Russia. ORCID
  3. Tatyana Lezheiko: Mental Health Research Center, 115522 Moscow, Russia.
  4. Victoria Plakunova: Mental Health Research Center, 115522 Moscow, Russia. ORCID
  5. Yulia Chaika: Mental Health Research Center, 115522 Moscow, Russia.
  6. Vera Golimbet: Mental Health Research Center, 115522 Moscow, Russia.

Abstract

BACKGROUND/OBJECTIVES: Schizophrenia is a clinically heterogeneous complex disorder with a substantial polygenic basis. The discovery of phenotypes indexing genetic differences advances research into the schizophrenia etiology but has proven to be challenging. The study aimed to further clarify the relationships of schizophrenia polygenic risk scores (SZ-PRSs) with a comprehensive array of schizophrenia antecedents and presentations using a culturally and ethnically homogeneous sample of schizophrenia spectrum patients.
METHODS: The top and bottom deciles ( = 172) of the SZ-PRS distribution in a group of 861 patients were compared on information derived from medical records using logistic regression.
RESULTS: High SZ-PRSs were associated with female sex, family history of a wide range of neuropsychiatric conditions, moderately poor premorbid social and cognitive adjustment in childhood, the schizophrenia diagnosis, and positive and "abnormal" psychomotor symptoms. The low-SZ-PRS group demonstrated an accumulation of both individuals with milder forms of SZ spectrum disorders and those with severe premorbid abnormalities in the social, cognitive, and neurological domains.
CONCLUSIONS: The results highlight moderately poor premorbid social and cognitive adjustment as characteristic manifestations of the polygenic component of the schizophrenia etiology and provide the first piece of PRS-based evidence for the long-standing idea of a higher liability threshold in women. The presence of milder and severe cases in the bottom SZ-PRS decile, suggesting its etiological heterogeneity, might be an important source of the inconsistency in the previous research on SZ-PRSs' relationship with schizophrenia phenotypes and should be considered in future studies.

Keywords

References

  1. Neuron. 2021 May 5;109(9):1465-1478.e4 [PMID: 33756103]
  2. Schizophr Bull. 2022 Jan 21;48(1):20-26 [PMID: 33987677]
  3. Sci Rep. 2023 Jun 9;13(1):9391 [PMID: 37296301]
  4. Lancet Psychiatry. 2019 Jul;6(7):610-619 [PMID: 31196794]
  5. Biomedicines. 2023 Apr 19;11(4): [PMID: 37189827]
  6. BMC Pediatr. 2020 Apr 21;20(1):178 [PMID: 32316954]
  7. Psychol Med. 2019 Nov;49(15):2499-2504 [PMID: 29501066]
  8. Am J Hum Genet. 2007 Sep;81(3):559-75 [PMID: 17701901]
  9. Rev Invest Clin. 2019;71(5):321-329 [PMID: 31599879]
  10. Schizophr Res. 2017 Jun;184:116-121 [PMID: 27916287]
  11. Behav Sci (Basel). 2023 Jul 12;13(7): [PMID: 37504028]
  12. Schizophr Bull. 2023 Jan 3;49(1):218-227 [PMID: 35947471]
  13. Epidemiol Psychiatr Sci. 2022 Sep 27;31:e68 [PMID: 36165168]
  14. J Pers Med. 2023 Jun 05;13(6): [PMID: 37373943]
  15. Nat Genet. 2017 Aug;49(8):1167-1173 [PMID: 28650482]
  16. Schizophr Res Cogn. 2018 Jan 28;12:11-19 [PMID: 29552508]
  17. Am J Psychiatry. 2020 Apr 1;177(4):298-307 [PMID: 31838871]
  18. Schizophr Res Treatment. 2020 Jul 23;2020:1638403 [PMID: 32774919]
  19. World Psychiatry. 2019 Jun;18(2):173-182 [PMID: 31059627]
  20. Transl Psychiatry. 2018 Aug 31;8(1):174 [PMID: 30171181]
  21. Asian J Psychiatr. 2021 Aug;62:102732 [PMID: 34118560]
  22. Addict Biol. 2018 Jan;23(1):485-492 [PMID: 28231610]
  23. Lancet Psychiatry. 2023 Jul;10(7):528-536 [PMID: 37353264]
  24. Nature. 2022 Apr;604(7906):502-508 [PMID: 35396580]
  25. Am J Hum Genet. 1983 Nov;35(6):1161-78 [PMID: 6650500]
  26. Bioinformatics. 2021 Apr 1;36(22-23):5424-5431 [PMID: 33326037]
  27. JAMA Psychiatry. 2020 May 1;77(5):523-533 [PMID: 32049274]
  28. Psychol Methods. 2005 Jun;10(2):178-92 [PMID: 15998176]
  29. JAMA Psychiatry. 2021 Oct 1;78(10):1143-1151 [PMID: 34347035]
  30. Mol Psychiatry. 2023 May;28(5):2081-2087 [PMID: 36914811]
  31. Nat Rev Neurol. 2024 Jan;20(1):7-21 [PMID: 38001363]
  32. S Afr J Psychiatr. 2020 Jul 28;26:1473 [PMID: 32832129]
  33. Am J Med Genet B Neuropsychiatr Genet. 2016 Mar;171B(2):276-89 [PMID: 26663532]
  34. Schizophr Res. 2023 Feb;252:161-171 [PMID: 36652833]
  35. Arch Womens Ment Health. 2024 Feb;27(1):11-20 [PMID: 37730924]
  36. Transl Psychiatry. 2023 Jun 13;13(1):201 [PMID: 37308478]
  37. Mol Psychiatry. 2023 Feb;28(2):883-890 [PMID: 36400854]
  38. Am J Psychiatry. 2019 Jan 1;176(1):29-35 [PMID: 30392412]
  39. Mol Psychiatry. 2019 Mar;24(3):409-420 [PMID: 29317742]
  40. Transl Psychiatry. 2021 Aug 10;11(1):423 [PMID: 34376640]
  41. J Affect Disord. 2017 Jan 15;208:604-609 [PMID: 28029428]
  42. Schizophr Res. 2022 Jun;244:29-38 [PMID: 35567871]
  43. World Psychiatry. 2018 Feb;17(1):49-66 [PMID: 29352556]
  44. Eur Arch Psychiatry Clin Neurosci. 2022 Apr;272(3):355-358 [PMID: 35284949]
  45. Cell. 2018 Jun 14;173(7):1705-1715.e16 [PMID: 29906448]

Grants

  1. 21-15-00124/Russian Science Foundation

Word Cloud

Created with Highcharts 10.0.0schizophreniapolygenicpremorbidrisksocialcognitiveSchizophreniaphenotypesresearchetiologyscoresSZ-PRSsusingspectrumpatientsbottomSZ-PRSgroupHighmoderatelypooradjustmentmildersevereBACKGROUND/OBJECTIVES:clinicallyheterogeneouscomplexdisordersubstantialbasisdiscoveryindexinggeneticdifferencesadvancesprovenchallengingstudyaimedclarifyrelationshipscomprehensivearrayantecedentspresentationsculturallyethnicallyhomogeneoussampleMETHODS:topdeciles=172distribution861comparedinformationderivedmedicalrecordslogisticregressionRESULTS:associatedfemalesexfamilyhistorywiderangeneuropsychiatricconditionschildhooddiagnosispositive"abnormal"psychomotorsymptomslow-SZ-PRSdemonstratedaccumulationindividualsformsSZdisordersabnormalitiesneurologicaldomainsCONCLUSIONS:resultshighlightcharacteristicmanifestationscomponentprovidefirstpiecePRS-basedevidencelong-standingideahigherliabilitythresholdwomenpresencecasesdecilesuggestingetiologicalheterogeneitymightimportantsourceinconsistencypreviousSZ-PRSs'relationshipconsideredfuturestudiesDemographicPremorbidClinicalCharacteristicsSpectrumPatientsLowPolygenicLiabilityDisorderPANSSfunctioningfactors

Similar Articles

Cited By

No available data.